Literature DB >> 9855103

Results of 546 Blalock-Taussig shunts performed in 478 patients.

K A Al Jubair1, M R Al Fagih, A S Al Jarallah, S Al Yousef, M A Ali Khan, A Ashmeg, Y Al Faraidi, W Sawyer.   

Abstract

Between 1983 and 1995, 546 Blalock-Taussig shunt procedures were performed in 472 patients: 128 (23.0%) were classical shunts, 90 of them on the same side as to the aortic arch, and 418 (77.0%) were modified shunts, 182 on the same side of the arch. At the time of surgery, 78 patients were aged below one week, 270 from one week to 12 months, and 198 patients were over one year of age. The mean pre-operative arterial saturation (71.7% +/- 16.5%) was significantly increased to 83% +/- 17.9% immediately after the procedure (p=0.017). The overall hospital mortality rate was 2.9% (16/546), with rates of 2.3% (3/128) for the classical, and 3.1% (13/418) for the modified shunts (p=not significant). The rate was significantly higher, however, for classical shunts when the pulmonary arterial diameter was less than 4 mm (15.4% versus zero; p=0.047), though this relationship was reversed for modified shunts (zero versus 3.6%; p=0.338). Early mortality was significantly influenced by the age at surgery, 5/78 (6.4%) in patients aged below 1 week, 3.7% between 1 week and 1 year, and 0.5% over 1 year (p=0.019). Early mortality was also significantly increased in patients weighing 3kg or less, 8/156 (5.1%), versus 3/303 (1.0%), p=0.037. Overall, 51 shunts failed (9.3%), 10 early and 41 late. Early failure was significantly increased in patients weighing 3kg or less, 8/156 (5.1%) versus 3/303 (1.0%), p=0.016. The overall early failure rate was 1.4% (3/215) when heparin was administered intra-operatively and for 48 hours postoperatively, in contrast to an early failure rate of 3.4% (7/203) when heparin was not used (p=0.294). Overall rates of failure during follow-up were 9.1% (17/188) in heparinized patients versus 13.6% (24/177), (p=0.173) in non-heparinized patients. Failure of classical shunts was 10.2% (13/128), compared with 6.7% (28/418) for modified shunts (p=0.195). Failure was more common overall if the pulmonary arterial diameter was less than 4 mm, 14.7% (9/61), as opposed to 8.7% (26/300) when the diameter was 4 mm or greater, (p=0.144). Administration of aspirin during follow-up after the modified shunt procedure reduced failure from 11% (18/163) to 6.7% (10/150), p=0.176. Classical or modified Blalock-Taussig shunts, either on the same side or opposite to the aortic arch, can be performed on patients of any age with minimum postoperative complications and low operative mortality. The use of intra- and post-operative heparin appears to reduce the overall rate of failure, and the administration of aspirin during follow-up appears to reduce failure of modified Blalock-Taussig shunts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855103     DOI: 10.1017/s1047951100007150

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  13 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Early mediastinal seroma secondary to modified Blalock-Taussig shunts--successful management by percutaneous drainage.

Authors:  Bairbre L Connolly; Michael J Temple; Peter G Chait; Ricardo Restrepo; Ian Adatia
Journal:  Pediatr Radiol       Date:  2003-03-28

Review 3.  Antiplatelet therapy in pediatric cardiovascular patients.

Authors:  Jennifer S Li; Jane W Newburger
Journal:  Pediatr Cardiol       Date:  2010-03-06       Impact factor: 1.655

4.  Computational fluid dynamics characterization of blood flow in central aorta to pulmonary artery connections: importance of shunt angulation as a determinant of shear stress-induced thrombosis.

Authors:  Carey Celestin; Martin Guillot; Nancy Ross-Ascuitto; Robert Ascuitto
Journal:  Pediatr Cardiol       Date:  2014-11-18       Impact factor: 1.655

Review 5.  Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.

Authors:  M D Reller
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

6.  Perioperative Factors Influence the Long-Term Outcomes of Children and Adolescents with Repaired Tetralogy of Fallot.

Authors:  Laura Mercer-Rosa; Xuemei Zhang; Ronn E Tanel; Jack Rychik; Mark A Fogel; Stephen M Paridon; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2018-06-06       Impact factor: 1.655

7.  Platelet Inhibition in Shunted Infants on Aspirin at Short and Midterm Follow-Up.

Authors:  Dongngan T Truong; Joyce T Johnson; David K Bailly; Jason R Clawson; Xiaoming Sheng; Phillip T Burch; Madolin K Witte; L LuAnn Minich
Journal:  Pediatr Cardiol       Date:  2016-12-30       Impact factor: 1.655

Review 8.  Impact of Medical Interventions and Comorbidities on Norwood Admission for Patients with Hypoplastic Left Heart Syndrome.

Authors:  Rohit S Loomba; Jacqueline Rausa; Juan S Farias; Enrique G Villarreal; Sebastian Acosta; Fabio Savorgnan; Saul Flores
Journal:  Pediatr Cardiol       Date:  2022-01-15       Impact factor: 1.655

9.  Axillary artery access for cardiac interventions in newborns.

Authors:  Dietmar Schranz; Ina Michel-Behnke
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  The effects of postoperative hematocrit on shunt occlusion for neonates undergoing single ventricle palliation.

Authors:  Brett R Anderson; Victoria L Blancha; Jennifer M Duchon; Paul J Chai; David Kalfa; Emile A Bacha; Ganga Krishnamurthy; Veniamin Ratner
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-14       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.